By Buy This GLP Editorial Team · Editorial profile: Neil Sanders
NuuVim review
Introductory and standard three-month pricing
NuuVim publishes separate first-term and standard charges.
A comparable monthly medication price is not available. See the plan details below for published fees, medication costs and payment terms.
The bottom line
NuuVim lists $237 for the first three months of compounded semaglutide and $399 at the standard rate. Compounded tirzepatide is $399 initially and $599 at the standard rate.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Pricing transparency
How NuuVim publishes its prices
When comparing the first term with the renewal, budget $399 per three months for semaglutide and $599 for tirzepatide at the standard rate. Ozari Select’s quarterly charges offer a comparison over the same three months for either medication. The advertised $79 and $133 monthly equivalents belong to the introductory three-month offers. Confirm the billing schedule and terms for the selected treatment.
At a glance
- Category
- GLP-1 sellers by price
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The seller
What NuuVim is
NuuVim offers injectable and oral liquid compounded products. Its price page shows the same three-month offer for both forms within each molecule.
How it works
Clinical assessment determines the treatment. NuuVim lists shipping, messaging and check-ins as included.
Branded or compounded
The FDA does not approve compounded medicines or review them before marketing for safety, effectiveness or quality.
Where the money holds, and where it moves
Predictable
- Publishes total charges for the first term and standard term
- Displays both injectable and oral liquid offers
Moves, or is not stated
- Opening rate is limited to the first three months
- Monthly figures describe three-month terms
Who this is worth it for
People who want the first and standard term totals in writing.
Who should price elsewhere
People looking for a clearly advertised month-to-month plan.
The molecules
What NuuVim prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide vs Injection: Wegovy Doses and Trial Results
In the US, Wegovy tablet maintenance is 25 mg daily. The usual recommended injection dose is 2.4 mg weekly for adults managing weight.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide in a head-to-head trial. A separate observational study found an uncertain difference in cardiovascular outcomes.
Priced against
Sellers to price beside NuuVim
Revel RXBuyers who will titrate up and want the maintenance price to match the opening price
See Revel RX →
CollectivePatients expecting sustained treatment who can use the membership year
See Collective →
MeasuredPeople who want ongoing care and can compare the two charges.
See Measured →
More GLP-1 sellers by price priced end to end: Ravia HealthRed Mountain Weight LossRegenCenRese WellnessRevive LongevityRila
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Frequently asked
Is $79 the recurring semaglutide price?
Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare NuuVim against every seller on it.